Overview
Forxiga 10 mg Tablets contain Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes mellitus, heart failure, and chronic kidney disease (CKD). By reducing glucose reabsorption in the kidneys, Forxiga enhances glucose excretion through urine. It not only aids in glycemic control but also offers protective benefits for the heart and kidneys, making it a vital therapeutic option in metabolic and cardiovascular health management.





